Mario Moisés Alvarez is a Rómulo Garza Insignia Professor at Tecnológico de Monterrey in México, where he holds affiliations at Centro de Biotecnología-FEMSA and at the Departamento de Bioingeniería. Together with Grissel Trujillo-de Santiago, he co-leads the Alvarez-Trujillo Laboratory, a research lab based at Centro de Biotecnología-FEMSA in Monterrey, México. Alvarez has been a Visiting Professor at the Harvard-MIT Health Sciences and Technology Program at the BWH, Harvard Medical School (2014-2016), and a Visiting Professor at the Microsystems Technology Laboratories (MTL) at the Massachusetts Institute of Technology (2015-2016). Alvarez also completed an industrial postdoctoral stay at the Institute of Pharmaceutical Technology at Bristol-Myers Squibb Company, USA (2000-2002). His research is focused on the integration of bio-, micro-, and nanotechnologies into tissue, biomedical, and biopharmaceutical engineering applications. His current academic production is mainly focused on bioprinting, biomaterial and tissue engineering, development of organ-on-chip systems, point of care diagnostics, and biopharmaceutical engineering.